Minimal Residual Disease (MRD) ratio before and after Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma

被引：0
作者：
Boncompagni, Riccardo [1 ]
Staderini, Michela [2 ]
Nozzoli, Chiara [1 ]
Antonioli, Elisabetta [2 ]
Caporale, Roberto [3 ]
Peruzzi, Benedetta [3 ]
Cutini, Ilaria [1 ]
Gozzini, Antonella [1 ]
Serena, Mariotti [1 ]
Guidi, Stefano [1 ]
Jance, Blerina [3 ]
Accogli, Barbara [2 ]
Francesco, Annunziato [3 ]
Bosi, Alberto [2 ]
Saccardi, Riccardo [1 ]
机构：
[1] AOU Careggi, Cell Therapy & Transfus Med Unit, Florence, Italy
[2] AOU Careggi, Hematol Unit, Florence, Italy
[3] AOU Careggi, Diagnost Ctr Cytometry & Immunotherapy, Florence, Italy
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
autologous stem cell transplant; Minimal residual disease; Progression-free survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP-203
引用
收藏
页码：E172 / E172
页数：1
相关论文
共 50 条
  • [41] Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma: Impact of Disease Risk and Post Allograft Minimal Residual Disease on Survival
    Dhakal, Binod
    D'Souza, Anita
    Martens, Michael
    Kapke, Jonathan
    Harrington, Alexandra M.
    Pasquini, Marcelo
    Saber, Wael
    Drobyski, William R.
    Zhang, Mei Jie
    Hamadani, Mehdi
    Hari, Parameswaran N.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (07) : 379 - 386
  • [42] Prognostic role of minimal residual disease in multiple myeloma patients after non-myeloablative allogeneic transplantation
    Galimberti, S
    Benedetti, E
    Morabito, F
    Papineschi, F
    Callea, V
    Fazzi, R
    Stelitano, C
    Andreazzoli, F
    Guerrini, F
    Ciabatti, E
    Martino, M
    Nobile, F
    Iacopino, P
    Petrini, M
    [J]. LEUKEMIA RESEARCH, 2005, 29 (08) : 961 - 966
  • [43] Minimal Residual Disease following Allogeneic Hematopoietic Stem Cell Transplantation
    Kroeger, Nicolaus
    Miyamura, Koichi
    Bishop, Michael R.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (01) : S94 - S100
  • [44] Prognostic value of minimal residual disease before allogeneic hematopoietic stem cell transplantation in patients with acute leukemia
    Konova, Z., V
    Parovichnikova, E. N.
    Galtseva, I., V
    Drokov, M. Yu
    Davydova, Yu O.
    Kapranov, N. M.
    Vasilyeva, V. A.
    Kuzmina, L. A.
    Savchenko, V. G.
    [J]. GEMATOLOGIYA I TRANSFUZIOLOGIYA, 2021, 66 (04): : 539 - 555
  • [45] Intensifying treatment in PET-positive multiple myeloma patients after upfront autologous stem cell transplantation
    Norgaard, Jakob Nordberg
    Abildgaard, Niels
    Lysen, Anna
    Tsykunova, Galina
    Vangsted, Annette Juul
    Joao, Cristina
    Remen, Nora
    Nielsen, Lene Kongsgaard
    Osnes, Liv
    Stokke, Caroline P.
    Connelly, James P.
    Revheim, Mona-Elisabeth R.
    Schjesvold, Fredrik
    [J]. LEUKEMIA, 2023, 37 (10) : 2107 - 2114
  • [46] Prognostic value of minimal residual disease among patients with classical Hodgkin lymphoma undergoing autologous stem cell transplantation
    Taranto, Eleanor
    Redd, Robert
    Jeter, Erin
    McHugh, Kristin
    Crombie, Jennifer L.
    Fisher, David C.
    Jacobsen, Eric
    Jacobson, Caron A.
    Kim, Austin, I
    LaCasce, Ann S.
    Odejide, Oreofe O.
    Dahi, Parastoo B.
    Nieto, Yago
    Joyce, Robin M.
    Chen, Yi-Bin
    Bonjoc, Kimberley-Jane C.
    Chaudhry, Ammar
    Herrera, Alex F.
    Armand, Philippe
    Merryman, Reid W.
    [J]. LEUKEMIA & LYMPHOMA, 2022, 63 (12) : 2912 - 2917
  • [47] Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma
    D'Angelo, Christopher
    Sudakaran, Sailendharan
    Asimakopoulos, Fotis
    Hematti, Peiman
    El-Gamal, Dalia
    Safdar, Nasia
    Callander, Natalie
    [J]. LEUKEMIA & LYMPHOMA, 2023, 64 (01) : 87 - 97
  • [48] Minimal residual disease in multiple myeloma: current status
    Ding, Hong
    Xu, Juan
    Lin, Zhimei
    Huang, Jingcao
    Wang, Fangfang
    Yang, Yan
    Cui, Yushan
    Luo, Hongmei
    Gao, Yuhan
    Zhai, Xinyu
    Pang, Weicui
    Zhang, Li
    Zheng, Yuhuan
    [J]. BIOMARKER RESEARCH, 2021, 9 (01)
  • [49] Combination of IFN-alpha/Gm-Csf as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (Asct): a Prospective Phase Ii Study
    Salmasinia, Donya
    Chang, Myron
    Wingard, John R.
    Hou, Wei
    Moreb, Jan S.
    [J]. CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2010, 4 : 117 - 125
  • [50] Advances in minimal residual disease monitoring in multiple myeloma
    Wijnands, Charissa
    Noori, Somayya
    van de Donk, Niels W. C. J.
    VanDuijn, Martijn M.
    Jacobs, Joannes F. M.
    [J]. CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2023, 60 (07) : 518 - 534
12345